Akari Therapeutics (AKTX) Assets Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51.28% |
| Jun 30, 2025 | 64.82% |
| Mar 31, 2025 | 37.85% |
| Dec 31, 2024 | -89.05% |
| Sep 30, 2024 | -42.94% |
| Jun 30, 2024 | 1.67% |
| Mar 31, 2024 | -29.29% |
| Dec 31, 2023 | 370.72% |
| Jun 30, 2023 | -17.85% |
| Dec 31, 2022 | 639.44% |
| Jun 30, 2022 | 35.09% |
| Mar 31, 2022 | 33.21% |
| Dec 31, 2021 | -1.87% |
| Sep 30, 2021 | 5.24% |
| Jun 30, 2021 | -34.41% |
| Mar 31, 2021 | -32.50% |
| Dec 31, 2020 | -99.12% |
| Sep 30, 2020 | -15.16% |
| Jun 30, 2020 | -23.32% |
| Mar 31, 2020 | -35.76% |
| Dec 31, 2019 | -99.21% |
| Sep 30, 2019 | -41.79% |
| Jun 30, 2019 | -56.91% |
| Mar 31, 2019 | -49.25% |
| Dec 31, 2018 | -24.17% |
| Sep 30, 2018 | -45.77% |
| Jun 30, 2018 | 79.50% |
| Mar 31, 2018 | 80.76% |
| Dec 31, 2017 | 2,532.37% |
| Dec 31, 2016 | 1,976.49% |
| Dec 31, 2015 | 4,268.97% |
| Dec 31, 2014 | 400.97% |